Presently, multiple histone deacetylase (HDAC) inhibitors have shown the ability to reverse the pathological hallmarks of AD and have produced good results in vitro and in vivo.12, 13, 14, 15. The gene discussed is HDAC9; the disease is Alzheimer disease.